World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33457635

Number of visits today: 5554

Number of downloads: 16640823

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Negrini M, Tomasello G, Davidsson M, Fenyi A, Adant C, Hauser S, Espa E, Gubinelli F, Manfredsson FP, Melki R, Heuer A. Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits. J Parkinsons Dis 2022;12:1133-53. [PMID: 35213388 DOI: 10.3233/JPD-212555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]

For:

Negrini M, Tomasello G, Davidsson M, Fenyi A, Adant C, Hauser S, Espa E, Gubinelli F, Manfredsson FP, Melki R, Heuer A. Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits. J Parkinsons Dis 2022;12:1133-53. [PMID: 35213388 DOI: 10.3233/JPD-212555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]

Number	Citing Articles
1	Er S, Airavaara M. Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease. Biochem Soc Trans 2023;51:245-57. [PMID: 36794783 DOI: 10.1042/BST20220770] [Reference Citation Analysis]
2	Gubinelli F, Sarauskyte L, Venuti C, Kulacz I, Cazzolla G, Negrini M, Anwer D, Vecchio I, Jakobs F, Manfredsson FP, Davidsson M, Heuer A. Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats. Curr Res Neurobiol 2023;4:100065. [PMID: 36632447 DOI: 10.1016/j.crneur.2022.100065] [Reference Citation Analysis]
3	Björklund A, Nilsson F, Mattsson B, Hoban DB, Parmar M. A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System. J Parkinsons Dis 2022;12:2307-20. [PMID: 36189605 DOI: 10.3233/JPD-223452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4	Pandey SK, Singh RK. Recent developments in nucleic acid-based therapies for Parkinson’s disease: Current status, clinical potential, and future strategies. Front Pharmacol 2022;13:986668. [DOI: 10.3389/fphar.2022.986668] [Reference Citation Analysis]
5	García-revilla J, Herrera AJ, de Pablos RM, Venero JL. Inflammatory Animal Models of Parkinson’s Disease. JPD 2022;12:S165-S182. [DOI: 10.3233/jpd-213138] [Reference Citation Analysis]
6	Gubinelli F, Cazzolla G, Negrini M, Kulacz I, Mehrdadian A, Tomasello G, Venuti C, Sarauskyte L, Jacobs F, Manfredsson F, Davidsson M, Heuer A. Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioural tests. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]